Articles |
From the Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, UK.
Correspondence to Dr Sarah Jane George, Bristol Heart Institute, University of Bristol, Bristol, BS2 8HW, UK. E-mail s.j.george{at}bristol.ac.uk
Abstract Vascular smooth muscle cell (VSMC) migration and proliferation are involved in the intimal thickening responsible for late vein graft failure. In addition to growth and chemotactic factors, VSMCs require expression of matrix-degrading enzymes, eg, metalloproteinases (MMP), to relieve the antiproliferative and antimigratory constraints of the extracellular matrix. Thapsigargin irreversibly inhibits Ca2+- ATPase, eliciting an increase in intracellular Ca2+ and depletion of the intracellular calcium pools that are thought to be involved in the control of VSMC migration, VSMC proliferation, and MMP activity. We therefore studied the effect of thapsigargin on VSMC migration, VSMC proliferation, and MMP expression in human saphenous vein organ cultures. Vein segments were cultured for 14 days, and VSMC proliferation and migration were determined by autoradiography. Cell death was assessed using in situ end-labeling and lactate dehydrogenase release. Using Western blotting, we examined MMP-2 and MMP-9 and tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 expression. Exposure to thapsigargin at 10 nmol/L for 60 minutes before culture significantly inhibited neointimal thickening (60%, P<.05), intimal and medial VSMC proliferation (32%, P<.05 and 37%, P<.05, respectively), and VSMC migration (36%, P<.05). Thapsigargin at 10 nmol/L did not significantly increase cell death or MMP-2, MMP-9, TIMP-1, and TIMP-2 expression. These results suggest that blockade of Ca2+-ATPase by thapsigargin inhibits VSMC migration and proliferation involved in neointimal formation without affecting MMP-2 and MMP-9 expression. Because short-term exposure to thapsigargin was sufficient to inhibit neointima formation, this drug may prove useful in the treatment of intimal thickening after arterial bypass graft surgery.
Key Words: metalloproteinases neointima calcium human saphenous vein smooth muscle cells
This article has been cited by other articles:
![]() |
W.-H. Fan and M. J. Karnovsky Increased MMP-2 Expression in Connective Tissue Growth Factor Over-expression Vascular Smooth Muscle Cells J. Biol. Chem., March 15, 2002; 277(12): 9800 - 9805. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Jiang, Q. Zhou, M. K. Yu, L. S. Ho, Z. N. Chen, and H. C. Chan The Involvement of HAb18G/CD147 in Regulation of Store-operated Calcium Entry and Metastasis of Human Hepatoma Cells J. Biol. Chem., December 7, 2001; 276(50): 46870 - 46877. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shukla, N. Freeman, P. Gadsdon, G.D. Angelini, and J.Y. Jeremy Thapsigargin inhibits angiogenesis in the rat isolated aorta: studies on the role of intracellular calcium pools Cardiovasc Res, February 16, 2001; 49(3): 681 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Stepien and P. Marche Amlodipine inhibits thapsigargin-sensitive CA2+ stores in thrombin-stimulated vascular smooth muscle cells Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1220 - H1227. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Overhaus, J. Heckenkamp, S. Kossodo, D. Leszczynski, and G. M. LaMuraglia Photodynamic Therapy Generates a Matrix Barrier to Invasive Vascular Cell Migration Circ. Res., February 18, 2000; 86(3): 334 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Jeremy, D. Rowe, A. M. Emsley, and A. C. Newby Nitric oxide and the proliferation of vascular smooth muscle cells Cardiovasc Res, August 15, 1999; 43(3): 580 - 594. [Full Text] [PDF] |
||||
![]() |
P. A. Outinen, S. K. Sood, S. I. Pfeifer, S. Pamidi, T. J. Podor, J. Li, J. I. Weitz, and R. C. Austin Homocysteine-Induced Endoplasmic Reticulum Stress and Growth Arrest Leads to Specific Changes in Gene Expression in Human Vascular Endothelial Cells Blood, August 1, 1999; 94(3): 959 - 967. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |